Cargando…

Nonphosphorylated tau slows down Aβ(1–42) aggregation, binds to Aβ(1–42) oligomers, and reduces Aβ(1–42) toxicity

The formation of neurofibrillary tangles and amyloid plaques accompanies the progression of Alzheimer's disease. Tangles are made of fibrillar aggregates formed by the microtubule-associated protein tau, whereas plaques comprise fibrillar forms of amyloid-beta (Aβ). Both form toxic oligomers du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beeg, Marten, Battocchio, Elisabetta, De Luigi, Ada, Colombo, Laura, Natale, Carmina, Cagnotto, Alfredo, Corbelli, Alessandro, Fiordaliso, Fabio, Diomede, Luisa, Salmona, Mario, Gobbi, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113980/ https://www.ncbi.nlm.nih.gov/pubmed/33865852 http://dx.doi.org/10.1016/j.jbc.2021.100664

Ejemplares similares

The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42
por: Gautieri, Alfonso, et al.
Publicado: (2019)

Amyloid β-peptides 1–40 and 1–42 form oligomers with mixed β-sheets
por: Baldassarre, Maurizio, et al.
Publicado: (2017)

Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils
por: Ahmed, Mahiuddin, et al.
Publicado: (2010)

Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β(1-42)
por: Bate, Clive, et al.
Publicado: (2004)

Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers
por: Novo, Mercedes, et al.
Publicado: (2018)

Capping of Aβ42 Oligomers by Small Molecule Inhibitors
por: Fu, Ziao, et al.
Publicado: (2014)

Effect of Lauric Acid on the Stability of Aβ(42) Oligomers
por: Khatua, Prabir, et al.
Publicado: (2021)

Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and function
por: Barucker, Christian, et al.
Publicado: (2015)

Aβ42 oligomers modulate β-secretase through an XBP-1s-dependent pathway involving HRD1
por: Gerakis, Yannis, et al.
Publicado: (2016)

Aβ1-6(A2V)(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury
por: Diomede, Luisa, et al.
Publicado: (2023)

Aβ42 pentamers/hexamers are the smallest detectable oligomers in solution
por: Wolff, Martin, et al.
Publicado: (2017)

Interaction of Aβ42 with Membranes Triggers the Self-Assembly into Oligomers
por: Banerjee, Siddhartha, et al.
Publicado: (2020)

Lysosomal Enzyme Glucocerebrosidase Protects against Aβ(1-42) Oligomer-Induced Neurotoxicity
por: Choi, Seulah, et al.
Publicado: (2015)

Microarray Analysis on Human Neuroblastoma Cells Exposed to Aluminum, β(1–42)-Amyloid or the β(1–42)-Amyloid Aluminum Complex
por: Gatta, Valentina, et al.
Publicado: (2011)

Structure of ring-shaped Aβ(42) oligomers determined by conformational selection
por: Tran, Linh, et al.
Publicado: (2016)

Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF‐like conformation of Tau protein
por: Manassero, Giusi, et al.
Publicado: (2016)

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
por: Constantinides, Vasilios C., et al.
Publicado: (2023)

Oleuropein Aglycone Protects Transgenic C. elegans Strains Expressing Aβ42 by Reducing Plaque Load and Motor Deficit
por: Diomede, Luisa, et al.
Publicado: (2013)

Cajaninstilbene Acid Ameliorates Cognitive Impairment Induced by Intrahippocampal Injection of Amyloid-β(1–42) Oligomers
por: Wang, Li-Sha, et al.
Publicado: (2019)

Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress
por: Caruso, Giuseppe, et al.
Publicado: (2021)

The intracerebral injection of Aβ(1-42) oligomers does not invariably alter seizure susceptibility in mice
por: Vande Vyver, Maxime, et al.
Publicado: (2023)

Distributions of Aβ42 and Aβ42/40 in the Cerebrospinal Fluid in View of the Probability Theory
por: Lewczuk, Piotr, et al.
Publicado: (2021)

Aggregation States of Aβ(1–40), Aβ(1–42) and Aβp(3–42) Amyloid Beta Peptides: A SANS Study
por: Festa, Giulia, et al.
Publicado: (2019)

Pyroglutamate-modified Aβ(3-42) affects aggregation kinetics of Aβ(1-42) by accelerating primary and secondary pathways
por: Dammers, C., et al.
Publicado: (2017)

Tau pathogenesis is promoted by Aβ1-42 but not Aβ1-40
por: Hu, Xiaoyan, et al.
Publicado: (2014)

The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers
por: Stravalaci, Matteo, et al.
Publicado: (2016)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
por: Klafki, Hans-Wolfgang, et al.
Publicado: (2022)

The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone
por: Delaby, Constance, et al.
Publicado: (2022)

Oligomer Formation by Amyloid-β42 in a Membrane-Mimicking Environment in Alzheimer’s Disease
por: Rosenberry, Terrone L., et al.
Publicado: (2022)

Amyloid β(1–42) Oligomers Induce Galectin–1(S8) O–GlcNAcylation Leading to Microglia Migration
por: Arrazola Sastre, Alazne, et al.
Publicado: (2023)

Effects and mechanism of amyloid β(1-42) on mitochondria in astrocytes
por: Yao, Yunyi, et al.
Publicado: (2018)

Intra‐gastrointestinal amyloid‐β1–42 oligomers perturb enteric function and induce Alzheimer's disease pathology
por: Sun, Yayi, et al.
Publicado: (2020)

Effects of Low Amyloid-β (Aβ) Concentration on Aβ(1–42) Oligomers Binding and GluN2B Membrane Expression
por: Gilson, Virginie, et al.
Publicado: (2015)

AβPP processing results in greater toxicity per amount of Aβ(1-42) than individually expressed and secreted Aβ(1-42) in Drosophila melanogaster
por: Bergkvist, Liza, et al.
Publicado: (2016)

Systematic Aβ Analysis in Drosophila Reveals High Toxicity for the 1-42, 3-42 and 11-42 Peptides, and Emphasizes N- and C-Terminal Residues
por: Jonson, Maria, et al.
Publicado: (2015)

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2016)

Conformational Essentials Responsible for Neurotoxicity of Aβ42 Aggregates Revealed by Antibodies against Oligomeric Aβ42
por: Song, Chuli, et al.
Publicado: (2022)

S100B chaperone multimers suppress the formation of oligomers during Aβ42 aggregation
por: Figueira, António J., et al.
Publicado: (2023)

Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40
por: Suire, Caitlin N., et al.
Publicado: (2020)

Combined Analysis of CSF Tau, Aβ42, Aβ1–42% and Aβ1–40(ox)% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia
por: Bibl, Mirko, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6eqa4jlfna7j3dcmuia1cac76e